Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RP | TSXV | CAD | Delayed | |
REPCF | OTC Markets | USD | Delayed |
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual’s own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company’s product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. The company was founded in 2006 and is headquartered in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
David M. Hall | 71 | 2010 | Independent Chairman of the Board |
Rolf Hoffmann | 62 | 2010 | Chief Medical Officer & Member of Clinical Advisory Board |
Peter Winston Lewis | 68 | 2011 | Independent Director |
R. Lee Buckler | 58 | 2014 | Director |
Ross G. Davidson | - | 2013 | Chairman of Clinical Advisory Board |
Jean Krutmann | - | - | Member of Clinical Advisory Board |
Andrew Schutte | 34 | 2018 | President, CEO & Director |
Tsukasa Kumai | - | - | Member of Clinical Advisory Board |
Akimichi Morita | - | 2021 | Member of Clinical Advisory Board |
Gary Boddington | 57 | 2021 | Independent Director |
Kunihiko Suzuki | 65 | 2021 | Senior Strategic Advisor to Directors |
Jamie MacKay | - | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review